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Research Article
Could an endoneurial endothelial crosstalk
between Wnt/b-catenin and Sonic
Hedgehog pathways underlie the early
disruption of the infraorbital blood–nerve
barrier following chronic constriction injury?
Nathan Moreau1,2, Annie Mauborgne1, Pierre-Olivier Couraud3,
Ignacio A Romero4, Babette B Weksler5, Luis Villanueva1,
Michel Pohl1 and Yves Boucher1,6
Abstract
Background: Blood–nerve barrier disruption is pivotal in the development of neuroinflammation, peripheral sensitization,
and neuropathic pain after peripheral nerve injury. Activation of toll-like receptor 4 and inactivation of Sonic Hedgehog
signaling pathways within the endoneurial endothelial cells are key events, resulting in the infiltration of harmful molecules and
immunocytes within the nerve parenchyma. However, we showed in a previous study that preemptive inactivation of toll-like
receptor 4 signaling or sustained activation of Sonic Hedgehog signaling did not prevent the local alterations observed
following peripheral nerve injury, suggesting the implication of another signaling pathway.
Methods: Using a classical neuropathic pain model, the infraorbital nerve chronic constriction injury (IoN-CCI), we
investigated the role of the Wnt/b-catenin pathway in chronic constriction injury-mediated blood–nerve barrier disruption
and in its interactions with the toll-like receptor 4 and Sonic Hedgehog pathways. In the IoN-CCI model versus control,
mRNA expression levels and/or immunochemical detection of major Wnt/Sonic Hedgehog pathway (Frizzled-7, vascular
endothelial-cadherin, Patched-1 and Gli-1) and/or tight junction proteins (Claudin-1, Claudin-5, and Occludin) readouts were
assessed. Vascular permeability was assessed by sodium fluorescein extravasation.
Results: IoN-CCI induced early alterations in the vascular endothelial-cadherin/b-catenin/Frizzled-7 complex, shown to
participate in local blood–nerve barrier disruption via a b-catenin-dependent tight junction protein downregulation. Wnt
pathway also mediated a crosstalk between toll-like receptor 4 and Sonic Hedgehog signaling within endoneurial endothelial
cells. Nevertheless, preemptive inhibition of Wnt/b-catenin signaling before IoN-CCI could not prevent the downregulation
of key Sonic Hedgehog pathway readouts or the disruption of the infraorbital blood–nerve barrier, suggesting that Sonic
Hedgehog pathway inhibition observed following IoN-CCI is an independent event responsible for blood–nerve barrier
disruption.
Conclusion: A crosstalk between Wnt/b-catenin- and Sonic Hedgehog-mediated signaling pathways within endoneurial
endothelial cells could mediate the chronic disruption of the blood–nerve barrier following IoN-CCI, resulting in increased
irreversible endoneurial vascular permeability and neuropathic pain development.
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Introduction
Peripheral nerve injuries induce multiple neuro-immune
and neurovascular alterations within the nerve’s
parenchyma. Most benign acute peripheral nerve injuries
eventually achieve complete recovery, but in some patho-
logical circumstances, however, nervehealing canbeunsuc-
cessful, leading to persistent neuroinﬂammation and the
development of neuropathic pain, a type of chronic pain
of very diﬃcult and often unsuccessful management.
Recent studies1–6 have underlined the importance
of early and sustained macrophage inﬁltration in this
process. This inﬁltration is possible via the pathological
disruption of the endoneurial blood–nerve barrier
(BNB),2 a monolayer of nonfenestrated endothelial
cells joined together by tight junctions (TJs) and adhe-
rens junctions (AJs) serving to protect the neural
parenchyma from external insults, such as the inﬁltration
of harmful cells and blood-borne toxins.7
In previous studies, using classical models of post-
traumatic neuropathic pain in rats (namely the sciatic
nerve chronic constriction injury (SN-CCI) and infraor-
bital nerve CCI (IoN-CCI)), we implicated the inhibition
of endoneurial endothelial Sonic Hedgehog (SHH) signal-
ing (a morphogen implicated in the regulation of blood–
brain barrier homeostasis in adults8) or the activation of
toll-like receptor 4 (TLR4) signaling (a pathogen-asso-
ciated molecular pattern/danger-associated molecular pat-
tern sensor of innate immunity) in the decreased
production of several key TJ proteins, such as Claudin-1,
Claudin-5, and Occludin. This resulted in increased local
vascular permeability, local immunocytes inﬁltration, and
neuropathic-like behavior development (mechanical allo-
dynia) in CCI-injured rats.4,5,9 Nevertheless, neither the
preemptive inhibition of TLR4 signaling nor the preemp-
tive activation of Hedgehog signaling in healthy nerves
could prevent the molecular, vascular, and behavioral
changes resulting from CCI, suggesting the possibility of
other players in this pathological context.
Recently, a growing body of evidence has underlined
the inﬂuence and importance of the Wnt/b-catenin mor-
phogenetic signaling pathway in vascular development,
pathological angiogenesis, and vascular permeabil-
ity.10–12 For instance, in mice, the genetic deletion of
Frizzled-7 (Fzd-7), a receptor of Wnt proteins and acti-
vator of canonical b-catenin signaling, resulted in the
disruption of AJ and increased vascular permeability
in vitro and in vivo.13
The Wnt pathway is a ubiquitous signaling pathway
found in most pluricellular organisms that plays major
roles not only in development but also in numerous dis-
eases in adulthood. Three signaling pathways have been
described: the Wnt/b-catenin (‘‘canonical’’) pathway, the
Wnt/Ca2þ pathway, and the planar cell polarity pathway.
Brieﬂy, in theWnt/b-catenin pathway, activation of mem-
brane Frizzled receptors by Wnt proteins induces a
downstream signal transduction leading to an inhibition
of the Axin/APC/GSK3b ‘‘destruction complex’’ that is
responsible—under resting conditions—for sequestration
and degradation of the b-catenin nuclear transcription
factor. The nondegraded b-catenin can thus accumulate
in the cytoplasm and migrate to the nucleus where it acts
as a nuclear transcription factor formany essential genes.14
Whereas several recent studies have suggested the
implication of Wnt signaling in neuropathic pain devel-
opment,15–19 there is scarce data regarding the role of
Wnt signaling in the disruption of the BNB following
peripheral nerve injury.
Using a classical model of neuropathic pain in rats, the
IoN-CCI, we investigated not only the possible implica-
tions of Wnt/b-catenin signaling in the early pathological
disruption of the endoneurial BNB and resulting neuroin-
ﬂammation but also the potential interactions of this
pathway with other key vascular permeability signaling
pathways (such as SHH- or TLR-mediated pathways),
as previously described.4,5
Methods
Animals
Adult male Sprague Dawley rats (200–250 g) were pur-
chased from Laboratoires Janvier (Le Genest-Saint-Isle,
France) and housed in a light- and temperature-con-
trolled environment (22 1C, 12/12 h light/dark cycle)
with food and water available ad libitum. All the animal
experiments performed in this study complied with
French and international laws and policies regarding the
use of animals in neuroscientiﬁc research (European
Communities Council Directive #87848, Octobre 1987,
Ministe`re de l’Agriculture et de la Foreˆt, Service
Ve´te´rinaire de la Sante´ et de la Protection animale;
Authorisation #00354.02, Comite´ d’Ethique, Universite´
Paris Descartes) and with the guidelines from the commit-
tee for research and ethical issues of the International
Association for the Study of Pain.20
Surgery
CCI of the IoN. Rats were deeply anesthetized using 3.6%
isoﬂurane in O2 at 3L/min for induction and 2.8%
isoﬂurane in O2 at 3L/min for maintenance. Right IoN
was exposed via an intraoral approach as previously
described.5,21 Brieﬂy, a 5-mm vestibular incision and
full-thickness ﬂap reﬂection allowed the exposure of
the right IoN at the emergence of the infraorbital
foramen. The nerve was further exposed using curved
forceps, and two ligatures (5-0 chromic catgut) were
loosely tied around the nerve without interrupting the
epineurial blood ﬂow, 2mm apart, at approximately
2mm from the foraminal emergence. The vestibular
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incision was then sewed up using 5-0 PROLENE sutures.
Sham animals were subjected to the same procedure, but
the IoN was only exposed without any direct contact or
ligature. CCI- and sham-injured rats were sacriﬁced by
isoﬂurane overdose at indicated time points after surgery
(3 h, 6 h, 24 h, seven days, 14 days; n¼ 5–8 rats per time
point), and approximately 7mm of IoN were harvested
at 2mm from the infraorbital foramen on both injured
and contralateral sides. Harvested tissue samples were
immediately frozen in liquid nitrogen and stored at
80C until further use.
Perineural injections. To investigate the impact of Wnt/
b-catenin-mediated pathways on IoN pathophysiology,
PKF 118-310 (a Frizzled-independent Wnt pathway
antagonist that prevents the nuclear translocation of
b-catenin) was injected in the close vicinity of the right
IoN using an intraoral transmucosal injection technique
as previously described.5 Each injection consisted of
50 mL of either PKF 118-310 (50 mM; Sigma-Aldrich,
Saint-Quentin Fallavier, France) or vehicle (NaCl
0.9%). Rats were pretreated 24 h before surgery (three
injections spaced 6 h apart), with the last injection occur-
ring during the surgical procedure (one half of injection
volume deposited on the exposed nerve and the other half
injected transmucosally after suture of the oral mucosa).
Evaluation of resulting molecular alterations and/or
BNB permeability was performed 3 h after last perineural
injection. After sacriﬁce, IoN samples were harvested and
immediately frozen in liquid nitrogen then stored at
80C, except for BNB permeability assessment (see
‘‘Evaluation of BNB permeability’’ section).
All the procedures described above were performed
by the same investigator (NM) so as to ensure the homo-
geneity and comparability of resulting data.
Evaluation of BNB permeability
BNB permeability was assessed using sodium ﬂuorescein
(NaFlu) as previously described.4,5,22 Brieﬂy, in rats
subjected to CCI or perineural injections, NaFlu was
injected intravenously (NaFlu, MW 376, 10% in saline,
2mL/kg; Sigma-Aldrich, Saint-Quentin Fallavier,
France) into the jugular vein under deep anesthesia
(sodium pentobarbital 50mg/kg, i.p.; Sanoﬁ, Libourne,
France) 3 h after the end of the corresponding surgical
procedure and allowed to circulate for 30min. Rats were
then sacriﬁced using a transcardial 100mL perfusion of
0.1% (w/v) paraformaldehyde (PAF; Sigma-Aldrich,
Saint-Quentin Fallavier, France) in 1X phosphate-buf-
fered saline (PBS; Sigma-Aldrich, Saint-Quentin
Fallavier, France). Approximately 7mm of IoN (at
2mm from its foraminal emergence) from both injured
and contralateral sides were harvested and post-ﬁxed in
4% PAF overnight, then transferred to 20% (w/v)
sucrose in PBS 1X for cyroprotection and frozen in iso-
pentane at 30C. Frozen IoN samples were embedded
in Tissue-Tek O.C.T compound (Sakura, Villeneuve
d’Ascq, France) and sliced both longitudinally and axi-
ally into 30 mm-thick sections using a cryostat microtome
(Leica CM3050S, Leica Microsystems, Nanterre,
France). Sections were then mounted on glass slides
and left to dry before being covered with
Fluoromount-G mounting medium (Southern Biotech,
Nanterre, France) and a glass coverslip. IoN sections
were examined using ﬂuorescence microscopy imaging
with a Leica TCS SP5 II confocal microscope (Leica
Microsystems, Nanterre, France).
Cell cultures
Immortalized human cerebral microvascular endothelial
cells (hCMEC/D3) were kindly provided by Dr. P.-O.
Couraud (INSERM U1016, France). The cells were cul-
tured in T75 tissue culture ﬂasks (BD Biosciences, Le
Pont de Claix, France) in endothelial cell basal
medium-2 (Lonza, Levallois-Perret, France) supple-
mented with 5% heat-inactivated fetal bovine serum
(Sigma-Aldrich, Saint-Quentin Fallavier, France), 10U/
mL penicillin, 10mg/mL streptomycin (Gibco, Villebon
sur Yvette, France), 1.4mM hydrocortisone (Sigma-
Aldrich, Saint-Quentin Fallavier, France), 5mg/mL
ascorbic acid (Sigma-Aldrich, Saint-Quentin Fallavier,
France), 1:100 chemically deﬁned lipid concentrate
(Gibco, Villebon sur Yvette, France), 10mM HEPES
(Sigma-Aldrich, Saint-Quentin Fallavier, France), and
1 ng/mL human basic ﬁbroblast growth factor (Sigma-
Aldrich, Saint-Quentin Fallavier, France) and main-
tained at 37C in a humidiﬁed incubator under 5%
CO2/95% O2. Cells were passaged once weekly or at
near 100% conﬂuence: culture medium was removed,
and cells were washed with PBS 1X (Gibco, Thermo
Fisher Scientiﬁc, Villebon-sur-Yvette, France) before
adding 5mL of 0.05% trypsin-EDTA 1X (Gibco,
Thermo Fisher Scientiﬁc, Villebon-sur-Yvette, France)
and left to incubate 5min at 37C. Cells were then har-
vested and centrifuged 5min at 1000 r/min; the cell pellet
was resuspended in 10mL culture medium for plating in a
new T75 ﬂask in a 1:10 ratio with fresh medium. For
pharmacological experiments and mRNA expression
levels assessment, 6-well plates were coated with
150mg/mL cultured rat collagen-I (R&D systems,
Minneapolis, MN, USA) diluted in water and incubated
at 37C for 1 h. Cells were then seeded at a density of
80,000 cells per square centimeter and further incubated
for 24 h before the experiments. Cells were then incubated
for 3 h with Wnt agonist I (5mM; Calbiochem, Merck,
Darmstadt, Germany; a Frizzled-independent agonist
of Wnt/b-catenin nuclear signaling), PKF 118-310
(2 mM; Sigma-Aldrich, Saint-Quentin Fallavier, France),
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or lipopolysaccharide (LPS) (300 ng/mL; Sigma-Aldrich,
Saint-Quentin Fallavier, France). To investigate the
impact of Wnt signaling on LPS-mediated molecular
alterations in vitro, cells were incubated 30min with
PKF 118-310 (2 mM; Sigma-Aldrich, Saint-Quentin
Fallavier, France) then challenged 4 h with LPS (200 ng/
mL; Sigma-Aldrich, Saint-Quentin Fallavier, France).
Following the treatment period, cells were washed in
PBS 1X, and total RNAs were extracted for reverse
transcription polymerase chain reaction (RT-PCR)
experiments (see below). Cells used for immunohisto-
chemistry experiments were treated as described above
then ﬁxed in PAF 4% and processed as described in the
‘‘Immunohistochemistry’’ section.
RNA extraction and semi-quantitative RT-PCR
Total RNAs from IoNs or cultured cells were
extracted using NucleoSpin RNA II Puriﬁcation kit
(Macherey-Nagel, Hoerdt, France), and a NanoDrop
spectrophotometer (ND-1000, ThermoFisher Scientiﬁc,
Villebon-sur-Yvette, France) was used to assess quality
and RNA concentrations from absorbance measure-
ments. For real-time RT-PCR analysis, ﬁrst-strand
complementary DNA (cDNA) synthesis from extracted
RNA was performed using the High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems,
Courtaboeuf, France) in accordance to manufacturer’s
instructions. Reverse transcription was followed by
real-time PCR ampliﬁcation of each sample in triplicate
using TaqMan Universal PCR Master Mix (Applied
Biosystems, Courtaboeuf, France), on an ABI Prism
7000 Sequence Detection System (Applied Biosystems,
Courtaboeuf, France). The following primers, purchased
from Life Technologies (Villebon-sur-Yvette, France),
were used in the present experiments: ribosomal protein
S18 (RPS18; Rn01428913_gH), glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH; Rn99999916_s1),
Claudin-1 (Rn00581740_m1), Claudin-5
(Rn01753146_s1), Occludin (Rn00580064_m1,
Hs00170162_m1), Patched-1 (Rn01527980_m1), glioma-
associated oncogene-1 (Gli-1; Rn01504237_m1), Fzd-7
(Rn01441541_m1, HS00275833_s1), b-catenin
(Rn01504237_m1, Hs00258305_m1), vascular endothe-
lial-cadherin (VE-cadherin; Rn01405893_m1,
Hs00170986_m1), vascular endothelial growth factor-A
(VEGF-A;Rn01511601_m1), toll-like receptor 2 (TLR2;
Rn02133647_s1), CD11b (Rn00709342_s1), chemokine
(CC motif) ligand 2 (CCL2; Rn00580555_m1), and
hypoxia-inducible factor-1a (HIF-1a;
Rn005777560_m1). Speciﬁc mRNA levels were calcu-
lated after normalization of the results for each sample
with those for GADPH or RSP18 mRNAs. Data are
presented as relative mRNA units with respect to con-
trol values (expressed as fold over control value).
Protein extraction and quantification
(enzyme-linked immunosorbent assay)
To assess the levels of VEGF-A protein within the IoN,
nerves from rats subjected to CCI were harvested at diﬀer-
ent time points (6 h, 24 h, 48 h, seven days) using the same
tissue collection methodology as for RNA extraction (see
corresponding sections for details). Total proteins and spe-
ciﬁc VEGF-A protein levels were assessed in IoN-CCI
nerve samples in triplicate using a speciﬁc enzyme-linked
immunosorbent assay (ELISA) kit (Rat VEGF-A ELISA
kit, EKB01917;Biomatik,Wilmington,DE,USA) accord-
ing to manufacturer’s instructions.
VEGF-A protein levels are expressed as the ratio of
the quantity of speciﬁc protein (VEGF-A) in picograms
(pg) over the quantity of total proteins (in pg).
Immunohistochemistry
For immunohistochemistry experiments, IoNs of sacri-
ﬁced rats were harvested as previously described (see
‘‘Evaluation of BNB permeability’’ section), or hCMEC/
D3 cells were ﬁxed in PAF 4% following speciﬁc pretreat-
ment (see ‘‘Cell cultures’’ section for details) and deposited
on glass slides. Slide-mounted 30mm-thick tissue sections
(or cells) were incubated in a blocking solution (3% horse
serum, 0.3% Triton X-100 in PBS) for 1 h at room tem-
perature. They were then incubated overnight at 4C
with rabbit anti-Reca 1 antibody (1:250; AbD
Serotec, Kidlington, UK) or rabbit anti-vWF
antibody (von Willebrand Factor; 1:500; Abcam,
Paris, France) as endothelial markers and goat
anti-Fzd-7 antibody (1:400; Santa Cruz, Heidelberg,
Germany), mouse anti-VE-cadherin antibody (1:250;
Santa Cruz, Heidelberg, Germany), or mouse anti-b-
catenin antibody (1:800; BD Bioscience, Le Pont de
Claix, France). Slides were then washed three times in
1X PBS and subsequently incubated with Alexa 488- or
Alexa 555-conjugated donkey anti-rabbit and donkey
anti-goat antibodies (Life technologies, Villebon-sur-
Yvette) diluted in PBS (1:600) thenwashed two times, incu-
bated in TO-PRO 3 (nuclear counterstain; 1:5000;
ThermoFischer Scientiﬁc, Villebon-sur-Yvette, France) for
5min and washed once again. Slides were then covered with
Fluoromount-G mounting medium (Southern Biotech,
Nanterre, France) and a glass coverslip and examined by
ﬂuorescence microscopy using a Leica TCS SP5 II confocal
microscope (Leica Microsystems, Nanterre, France).
Data and statistical analyses
All data are presented as mean standard error of the
mean. For RT-PCR experiments, the 2Ct method23
was used to analyze the relative diﬀerences in speciﬁc
mRNA levels between groups (RQ Study Software 1.2
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version; Applied Biosystems, Courtaboeuf, France); data
were then analyzed using one-way analysis of variance
(ANOVA) followed by Bonferroni post hoc test (for
time-dependent mRNA expression changes), Kruskal–
Wallis test followed by Dunn’s multiple comparison test
(for other conditional mRNA expression changes), or
Mann–Whitney test when appropriate. For protein quan-
tiﬁcation, speciﬁc protein levels at selected time points
were compared to control levels using one-way ANOVA
followed by Bonferroni post hoc test. GraphPad Prism 5
(GraphPad Software Inc., SanDiego, CA, USA) was used
for statistical analyses. Level of signiﬁcance was set at
p< 0.05.
Results
IoN-CCI induces early and transient alterations in
the endoneurial endothelial AJ complex in
association with a transient increased production
of VEGF-A protein in the rat’s IoN
In order to investigate the possible implications of the
Wnt/b-catenin signaling pathway in the increased vascu-
lar permeability following IoN-CCI, we explored the
expression levels of key mRNAs implicated in the endo-
thelial AJ complex, i.e. the functional tripartite associ-
ation of endothelial membrane receptor Fzd-7 (a key
Wnt pathway receptor) with VE-cadherin (the main
endothelial AJ protein) and intracellular b-catenin (the
main eﬀector of canonical Wnt signaling) attached to the
cytoplasmic tail of VE-cadherin.13,24 Present investiga-
tions were restricted to the early events following IoN-
CCI, i.e. the functional and molecular alterations during
the ﬁrst two weeks following IoN injury as described in
the initial model.25
Following IoN-CCI, a signiﬁcant downregulation
of Fzd-7 mRNA could be observed as early as 3 h
and sustained till at least 48 h post-CCI. A signiﬁcant
downregulation of VE-cadherin mRNA expression
levels could also be observed at 24 h post-CCI.
No signiﬁcant modiﬁcations of b-catenin mRNA expres-
sion levels could be observed in the studied timeframe
(Figure 1(a)).
Fzd-7-like immunoreactive material (in green) could be
observed in longitudinal slices of IoNs submitted to CCI
(24h post-injury) or sham injury (control), which coloca-
lized with Reca-1-stained perineurial and endoneurial cells
(in red), conﬁrming the endothelial expression of the recep-
tor in the present experimental conditions. Furthermore,
global Fzd-7 immunoreactivity was notably lower in the
CCI condition (24 h post-CCI) than in sham-injured ani-
mals (control) (Figure 1(b)). This was conﬁrmed in axial
slices of endoneurial blood vessels, where Fzd-7 immunor-
eactivity was also clearly lower in the CCI condition (24h
post-CCI) than in sham-injured animals investigated in the
same time point (Figure 1(c)). Similar alterations in VE-
cadherin immunoreactivity were observed in the CCI con-
dition (24 h post-CCI) compared to sham-injured animals,
using the same methodology (Figure 1(d)).
These results suggest a decreased production of Fzd-7
and VE-cadherin, in endoneurial endothelial cells
(EECs) of IoNs at 24 h post-CCI.
A study focusing on the role of Fzd-7 as a key regu-
lator of endothelial vascular permeability has suggested
that lack of Fzd-7 expression in KO-mice was responsible
for the disorganization of endothelial AJ, resulting not
only in the separation and spacing of adjacent endothelial
cells but also in diminished VE-cadherin and Claudin-5
expression levels13 in accordance with other authors.24,26
In our previous study focusing on the endoneurial endo-
thelial molecular alterations following IoN-CCI, a signiﬁ-
cant decrease in TJ protein Claudin-5 was evidenced as
early as 3 h post-CCI and sustained for at least 14 days.5
Together with the present results, these data provide evi-
dence of signiﬁcant alterations in AJ and TJ architecture
in endoneurial blood vessels of IoNs submitted to CCI.
To further elucidate the mechanisms implicated in
the disruption of the AJ complex and subsequent
increased vascular permeability, we investigated the
potential implication of VEGF-A, a key permeability-
inducing factor, known to induce VE-cadherin
phosphorylation and internalization, resulting in the
dissociation of associated b-catenin,27 allowing its
nuclear translocation and subsequent inhibition of
Claudin-5 promoter activity.24
Following IoN-CCI, a signiﬁcant increase in VEGF-
A mRNA expression levels was observed at 24 h post-
CCI. An increased production of VEGF-A was also
observed between 6 h and 48 h (reaching statistical
signiﬁcance at 48 h post-CCI) (Figure 1(e)). The timing
for increased VEGF-A protein production coincided
with the lowest VE-cadherin and Fzd-7 expression
levels (namely, at 24 h post-CCI), coherent with a
VEGF-mediated VE-cadherin downregulation.
In vitro, activation of Wnt/-catenin pathway
downregulates VE-cadherin mRNA, whereas
inhibition of Wnt/-catenin pathway upregulates
VE-cadherin/Fzd-7 complex in the hCMEC/D3 cell line
To further investigate the implication of Wnt/b-catenin
pathway in the increased vascular permeability following
IoN-CCI, we explored whether Wnt signaling could
modulate the expression levels of key elements of the
AJ complex in vitro, in immortalized hCMEC/D3 cell
line, a validated blood–brain barrier model.
Confocal microscopy imaging of conﬂuent hCMEC/
D3 cells showed a cytoplasmic accumulation of Fzd-7-
like immunoﬂuorescence (green) in association with a
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Figure 1. Chronic constriction injury of the infraorbital nerve (IoN-CCI) induces early and transient alterations in the Fzd-7/b-catenin/
VE-cadherin AJ complex within endoneurial endothelial cells in association with a transient increased production of VEGF-A protein in the
infraorbital nerve. (a) IoN-CCI induces early and transient significant downregulation of Fzd-7 and VE-cadherin mRNAs and early
upregulation followed by transient downregulation of b-catenin mRNA expression levels. Changes over time of Fzd-7, b-catenin, and VE-
cadherin mRNA levels were assessed in the IoN of sham- or CCI-injured animals using semi-quantitative RT-PCR analyses. Data are
presented as relative quantification (R.Q.) in arbitrary units (A.U.) corresponding to the ratio of specific mRNA over RPS18 mRNA. Each
bar corresponds to the mean SEM of n¼ 5–8 animals for each time point (post-injury); *p< 0.05, **p< 0.01, ***p< 0.001. A one-way
ANOVA followed by Bonferroni post hoc test was used. (b, c) IoN-CCI induces a decrease in Fzd-7 immunoreactivity in endoneurial blood
vessels compared to control condition (sham-injured animals) at 24 h post-CCI in longitudinal slices of the injured IoN (b) and in axial slices
centered on an endoneurial blood vessel (Scale bar¼ 100mm) (c). No Fzd-7 immunoreactivity was observed outside of the endoneurial
endothelial cells. Paraformaldehyde-fixed slices of IoN from sham- and CCI-injured rats were incubated with TO-PRO (nuclear stain, blue),
anti-Reca 1 antibodies (endothelial marker, red), and anti-Fzd-7 antibodies (green) (Scale bar¼ 10 mm). (d) IoN-CCI induces a decrease in
VE-cadherin immunoreactivity in endoneurial blood vessels compared to control condition (sham-injured animals) at 24 h post-CCI in axial
slices of the injured IoN. Paraformaldehyde-fixed slices of IoN from sham- and CCI-injured rats were incubated with TO-PRO (nuclear
stain, blue), anti-Reca 1 antibodies (endothelial marker, red), and anti-VE cadherin antibodies (green) (Scale bar¼ 10 mm). (e) IoN-CCI
induces a transient increase in VEGF-A mRNA expression levels at 24 h followed by a significant downregulation between 48 h and seven
days (left figure) associated with a significant increase in VEGF-A protein production between 24 h and 48 h post-CCI (right figure).
Changes over time of VEGF-A mRNA levels were assessed in the IoN of sham- or CCI-injured animals using semi-quantitative RT-PCR
analyses. Data are presented as R.Q. in A.U. corresponding to the ratio of specific mRNA over RPS18 mRNA. Each bar corresponds to the
mean SEM of n¼ 5–8 animals for each time point (post-injury); *p< 0.05, **p< 0.01, ***p< 0.001; one-way ANOVA followed by
Bonferroni post hoc test was used.
Changes over time in VEGF-A protein production in CCI-injured animals (compared to sham-injured animals) were assessed using an
enzyme-linked immunosorbent assay (ELISA) technique. Data are presented as the ratio of VEGF-A protein (in pg) over total proteins (in
mg). Each bar corresponds to n¼ 3 rats for each time point (post-injury); *p< 0.05; one-way ANOVA followed by Bonferroni post hoc test
was used.
VE: vascular endothelial; AJ: adherens junction; VEGF-A: vascular endothelial growth factor-A; RT-PCR: reverse transcription polymerase
chain reaction; SEM: standard error of the mean; Fzd-7: Frizzled-7; ANOVA: analysis of variance.
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Figure 1. Continued.
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membrane b-catenin immunoﬂuorescence (red) under
basal conditions (Figure 2(a)) conﬁrming the presence
of Fzd-7 within this endothelial cell line.
Activation of Wnt/b-catenin pathway (using Wnt
agonist I; 5 mM) resulted in a trend toward VE-cadherin
mRNA downregulation, whereas inhibition of Wnt/
b-catenin pathway (using PKF 118-130; 2 mM) induced
a signiﬁcant downregulation of b-catenin mRNA levels.
Furthermore, a signiﬁcant upregulation of Fzd-7 and
VE-cadherin mRNA expression levels could be observed
in PKF 118-310-treated cells as compared to Wnt
agonist I-treated cells (Figure 2(b)).
These results suggest that Wnt/b-catenin pathway
could modulate endothelial VE-cadherin/Fzd-7/b-catenin
complex mRNA expression levels in vitro. Furthermore,
when comparing the molecular alterations observed fol-
lowing in vitro treatment with Wnt agonist I and PKF
118-310, with in vivo mRNA expression levels following
IoN-CCI, these results also suggest that IoN-CCI could
lead to the activation of Wnt/b-catenin signaling.
In vitro, activation of Wnt/-catenin pathway in
hCMEC/D3 endothelial cells downregulates the
mRNAs of key Hedgehog pathway readouts and
mediates the molecular changes observed following
TLR4 stimulation
Previous studies focusing on the interactions between
VE-cadherin and Claudin-5 have suggested close inter-
actions between AJ proteins and TJ proteins in the
regulation of vascular permeability.24,26 We therefore
sought to investigate whether the Wnt/b-catenin path-
way could be implicated in the regulation of TJ pro-
teins expression levels, possibly via interactions with
SHH- and/or TLR4-mediated signaling pathways,
both of which having previously been implicated in
TJ proteins expression changes in vitro (in hCMEC/
D3 cells) and in vivo.4
In vitro, in the hCMEC/D3 cell line, activation of
Wnt pathway (using Wnt agonist I; 5 mM) resulted in a
signiﬁcant downregulation of key eﬀectors of the
Figure 2. In vitro, in the human cerebral microvascular endothelial cell line (hCMEC/D3), modulation of Wnt/b-catenin pathway induces
significant expression changes in the VE-cadherin/Fzd-7/b-catenin complex mRNAs levels. (a) Presence of functional Frizzled-7 within the
hCMEC/D3 endothelial cells was assessed using immunofluorescent labeling of Frizzled-7, b-catenin, and TO-PRO observed with confocal
microscopy imaging. Paraformaldehyde-fixed cells were incubated with anti-Frizzled-7 antibodies (green), anti-b-catenin (cell membrane
surrogate marker, red), and TO-PRO (nuclear stain, blue) (Scale bar¼ 20mm). (b) Changes in Frizzled-7, b-catenin, and VE-cadherin
mRNAs expression levels were assessed in vitro following stimulation with either Wnt agonist I (5 mM; Wnt pathway agonist) or PKF 118-
310 (2mM; Wnt pathway antagonist). Data are presented as relative quantification (R.Q.) in arbitrary units (A.U.) corresponding to the
ratio of specific mRNA over RPS18 mRNA. Each bar corresponds to the mean SEM of n¼ 4 experiments for each condition; *p< 0.05,
**p< 0.01, ***p< 0.001; Kruskal–Wallis test followed by Dunn’s multiple comparisons test was used.
VE: vascular endothelial; SEM: standard error of the mean.
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Hedgehog pathway mRNAs, namely the transcription
factor Gli-1 and the receptor Patched-1 (Figure 3(a)).
Furthermore, following a pretreatment with TLR4
agonist LPS, nuclear and perinuclear accumulation of
b-catenin (green) could be observed in hCMEC/D3
cells using immunoﬂuorescence confocal microscopy
(Figure 3(b)), suggestive of Wnt/b-catenin pathway acti-
vation14 following TLR4-mediated pathway activation.
To conﬁrm these results, we investigated whether inhib-
ition of Wnt pathway (using PKF 118-130; 2 mM) could
mitigate the molecular alterations observed following
TLR4 stimulation (using LPS; 300 ng/mL). Indeed,
in vitro, treatment with PKF 118-310 reversed the
molecular alterations resulting from LPS stimulation,
such as the TJ protein Claudin-5, the SHH pathway
readout Gli-1, and the inﬂammatory marker TLR2
(Figure 3(c)).
Globally, these results indicate that the Wnt/b-cate-
nin pathway could mediate the previously demon-
strated crosstalk between TLR4 activation and SHH
pathway repression.4 Furthermore, active Wnt signal-
ing could mediate the molecular changes (such as TJ
protein downregulation) following an inﬂammatory
challenge (LPS).
Figure 3. In vitro, in the hCMEC/D3 cell line, activation of Wnt/b-catenin pathway downregulates the mRNAs of key Hedgehog pathway
readouts and mediates the molecular changes observed following TLR4 stimulation. (a) Changes in Gli-1 or Patched-1 mRNAs expression
levels were assessed in vitro following stimulation with either Wnt agonist I (5mM; Wnt pathway agonist) or PKF 118-310 (2mM; Wnt
pathway antagonist). Data are presented as relative quantification (R.Q.) in arbitrary units (A.U.) corresponding to the ratio of specific
mRNA over RPS18 mRNA. Each bar corresponds to the mean SEM of n¼ 4 experiments for each condition; *p< 0.05, **p< 0.01,
***p< 0.001; Kruskal–Wallis test followed by Dunn’s multiple comparisons test was used. (b) In vitro, following pretreatment with LPS
(a TLR4 agonist), an important increase in b-catenin immunoreactivity could be observed at the cell membrane and in the nuclear and
perinuclear regions observed in confocal microscopy imaging, suggestive of Wnt pathway activation. Paraformaldehyde-fixed cells were
incubated with anti-b-catenin antibodies (green) and TO-PRO (nuclear stain, blue) (Scale bar¼ 30mm). (c) Changes in Claudin-5, Gli-1, and
TLR2 mRNAs expression levels were assessed in vitro, following LPS stimulation or PKF 118-310 pretreatment followed by LPS stimu-
lation. PKF 118-310 pretreatment strongly mitigated the changes in mRNA expression levels of all three markers, suggesting that TLR4-
mediated molecular changes (LPS stimulation) are mediated by active Wnt signaling. Data are presented as R.Q. in A.U. corresponding to
the ratio of specific mRNA over RPS18 mRNA. Each bar corresponds to the mean SEM of n¼ 4 experiments for each condition;
*p< 0.05, **p< 0.01, ***p< 0.001; Kruskal–Wallis test followed by Dunn’s multiple comparisons test was used.
hCMEC/D3: human cerebral microvascular endothelial cells; TLR4: toll-like receptor 4; SEM: standard error of the mean; LPS:
lipopolysaccharide.
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Figure 4. In vivo, at 3 h post-injury, inhibition of Wnt/b-catenin signaling could not prevent the molecular and vascular alterations
following infraorbital nerve chronic constriction injury (IoN-CCI). (a to d) Changes in mRNAs expression levels of TJ proteins Claudin-1,
Claudin-5, Occludin (a), inflammatory markers TLR2 and CD11b (b), Hedgehog pathway markers Patched-1 and Gli-1 (c), and Fzd-7/
b-catenin/VE-cadherin AJ complex proteins (d) were assessed using semi-quantitative RT-PCR following either perineural injections (used
as a control condition), or infraorbital nerve chronic constriction injury (CCI) following either PKF 118-310 (50 mM; Wnt pathway
antagonist) or NaCl 0.9% injections (three injections, spaced 6 h apart, starting 24 h before injury), as compared to noninjured IoN of naı¨ve
rats (serving as baseline values for mRNA levels comparisons). Data are presented as relative quantification (R.Q.) in arbitrary units (A.U.)
corresponding to the ratio of specific mRNA over RPS18 mRNA. Each bar corresponds to the mean SEM of n¼ 5–8 animals for each
time point (post-injury); *p< 0.05, **p< 0.01, ***p< 0.001. Kruskal–Wallis test followed by Dunn’s multiple comparisons test was used.
(e) Fluorescence microscopy observation of paraformaldehyde-fixed axial and longitudinal slices of right IoNs harvested from NaFlu
intravenously injected rats submitted to perineural injection or CCI following either PKF 118-310 (Wnt pathway antagonist) or NaCl 0.9%
injections (three injections, spaced 6 h apart, starting 24 h before injury) showed an increase in NaFlu fluorescence within the IoN
parenchyma following IoN-CCI in both PKF 118-310 and NaCl 0.9% pretreated rats (as compared to control conditions), suggesting that
Wnt/b-catenin inhibition could not mitigate the vascular alterations following IoN-CCI (Scale bar¼ 50mm).
TJ: tight junction; TLR2: toll-like receptor 2; VE: vascular endothelial; Fzd-7: Frizzled-7; AJ: adherens junction; RT-PCR: reverse transcription
polymerase chain reaction; NaFlu: sodium fluorescein.
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In vivo, inhibition of Wnt/-catenin pathway does not
prevent the early molecular and vascular alterations
following IoN-CCI
As active Wnt/b-catenin pathway results in SHH path-
way eﬀectors downregulation in vitro, and considering
our previous results that showed a major contribution of
Hedgehog pathway inhibition in the molecular, vascular,
and behavioral changes following CCI, we then focused
our investigations on the impact of active Wnt/ b-catenin
signaling on CCI-mediated molecular alterations in vivo
in the IoN-CCI model.
In vivo, at 3 h post-injury, inhibition of Wnt signaling
(via preemptive perineural injections of PKF 118-310)
could not mitigate the mRNA levels of TJ protein
Claudin-1, Claudin-5, and Occludin (Figure 4(a));
Figure 4. Continued.
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inﬂammatory marker TLR2; macrophage marker
CD11b (Figure 4(b)); Hedgehog pathway readouts
Patched-1 and Gli-1 (Figure 4(c)); and AJ complex elem-
ents VE-cadherin, Fzd-7, and b-catenin (Figure 4(d)) fol-
lowing IoN-CCI. Furthermore, preemptive inhibition of
Wnt signaling (via PKF 118-310 perineural injections)
could not prevent the increased vascular permeability, evi-
denced as intraparenchymal accumulation of NaFlu in the
IoN, following CCI, as compared to vehicle (NaCl 0.9%)
perineural injections (control condition). Noninjured
nerves subjected to PKF 118-310/NaCl 0.9% injections
(Injection) served as indicators of baseline ﬂuorescence
(Figure 4(e)). These results suggest that inhibition of
Wnt/b-catenin pathway cannot prevent the molecular
and vascular alterations resulting from IoN-CCI.
As Wnt/b-catenin pathway inhibition did not miti-
gate the downregulation of SHH pathway readouts
(Figure 4(c)) and considering the previously shown
role of SHH pathway inhibition in BNB disruption,5
both pathways could independently modulate the
expression of key TJ proteins (such as Claudin-5)
leading to BNB disruption and eventually neuro-
pathic pain development.
Discussion
Wnt/-catenin pathway is implicated in the disruption
of the endoneurial BNB following IoN-CCI
Peripheral nerve injuries mediate numerous local
molecular changes implicated not only in the physio-
logical healing process but also in the pathological
alterations resulting in neuropathic pain development.
Disruption of the endoneurial BNB following periph-
eral nerve injury has been shown to mediate a local
increase in vascular permeability, allowing the passage
of harmful molecules and immunocytes, resulting in
local neuroinﬂammation, peripheral sensitization, and
neuropathic pain.2,4,5 On a molecular level, this dis-
rupted endothelial barrier stems from a major down-
regulation of key TJ proteins (such as Claudin-1,
Claudin-5, and Occludin) within the EECs, under the
regulation of at least two key signaling pathways,
namely active TLR4 signaling or inactive SHH signal-
ing.4,5 Nevertheless, as inactive TLR4 signaling and/or
active SHH signaling do not mitigate the molecular
alterations in the endoneurial BNB following peripheral
nerve injury, other signaling pathways could be impli-
cated in such molecular alterations.
The present study focused on the potential implica-
tions of the Wnt/b-catenin pathway, a morphogenetic
pathway implicated in the regulation of vascular perme-
ability, in the molecular alterations following IoN-CCI,
a classical preclinical model of post-traumatic trigeminal
neuropathic pain.
Several recent studies have underlined an important
role of Wnt signaling in the development of neuropathic
pain. For instance, an upregulation of b-catenin and
Wnt3a was observed in the spinal dorsal horn following
L5 spinal nerve ligation28 and CCI,29 suggesting that Wnt
pathway activation in the spinal cord could be a common
essential event in neuropathic pain development.15
Furthermore, activation of Wnt pathway could induce
an increased production of pro-inﬂammatory cytokines
interleukin-18 and tumor necrosis factor alpha in the
spinal cord that participates in the development of neuro-
pathic pain.29 Nevertheless, little attention has been given
to the implication of Wnt signaling in the microvascular
alterations observed following peripheral nerve injury.
In the present study, following IoN-CCI, an early and
sustained downregulation of Fzd-7, a key eﬀector of Wnt
signaling and major regulator of vascular permeability,13
could be observed in association with a downregulation
of the major AJ protein VE-cadherin within the EECs.
Furthermore, a transient increased production of VEGF
protein between 6 h and 48 h post-injury could be
observed in the parenchyma of IoNs subjected to CCI.
This key pro-permeability factor mediates an increase in
vascular permeability via the internalization of VE-cad-
herin, resulting in the disruption of endothelial AJ and
TJ.24,27 Interestingly, a previous study has shown the
major implication of VEGF signaling in peripheral sen-
sitization and neuropathic pain development,30 whereas
another study has shown that the BNB disruption
observed following partial ligation of the sciatic nerve
could be mediated by a local release of VEGF from resi-
dent macrophages.2
In vitro, in a model of blood–brain barrier endothelial
cells, activation of Wnt/b-catenin signaling mediated not
only a downregulation in key readouts of the Hedgehog
pathway (namely Patched-1 and Gli-1) but also the
molecular alterations resulting from TLR4 stimulation,
suggesting that, in this model, Wnt/b-catenin signaling
could play a major role in the crosstalk between TLR4
and SHH signaling pathways. Furthermore, compari-
son of in vivo (Figure 1(a)) and in vitro (Figure 2(b))
mRNA expression levels of key Wnt pathway readouts
suggests that IoN-CCI could lead to Wnt/b-catenin
pathway activation. This activation could result from
increased local hypoxia within the IoN, as suggested
by a signiﬁcant increase in HIF-1a mRNA observed
at 3 h following IoN-CCI (Figure 5) (also observed
in our previous results in a sciatic CCI model4).
Indeed, previous studies have shown an activation of
Wnt/b-catenin pathway under hypoxic conditions and
an increase in vascular permeability in response to an
hypoxic insult.31,32 Furthermore, a recent study by Lim
et al.33 has underlined the role of endoneurial hypoxia
resulting from peripheral nerve injury in the genesis of
neuropathic pain.
12 Molecular Pain
In vivo, inhibition of Wnt/b-catenin signaling could
not mitigate the molecular and vascular alterations
observed following IoN-CCI, suggesting that active
Wnt/b-catenin signaling is not alone suﬃcient to mediate
the molecular and vascular alterations in this neuro-
pathic pain model. This is consistent with our previous
research that showed a signiﬁcant role of the inhibition
of endoneurial endothelial SHH signaling following sci-
atic nerve and IoN-CCI models.4,5 Therefore, activation
of Wnt/b-catenin and concurrent inhibition of SHH
pathways could be required for CCI-induced infraorbital
BNB disruption.
An endoneurial endothelial Wnt/SHH pathways
crosstalk could mediate the molecular alterations
following IoN-CCI
In an previous study, we had shown that the CCI of
the sciatic nerve was associated with a transient
increase in SHH protein mRNA expression level
associated with a concurrent signiﬁcant downregula-
tion of key downstream eﬀectors Patched-1 and Gli-
1, suggesting that inhibition of Hedgehog signaling
following CCI does not result from decreased produc-
tion of SHH but rather from downregulation of
underlying eﬀectors.4 Furthermore, downregulation
of VE-cadherin is associated with a disorganization
of AJ and TJ proteins at the cell surface24 and sub-
sequent loss of cell polarity,34 leading to loss of
primary cilium in the cell,35 a vital component of
the endothelial cell membrane, mandatory for func-
tional Hedgehog signaling. Therefore, downregulation
of VE-cadherin resulting from CCI could induce the
loss of endothelial cell polarity, subsequent loss of
primary cilium, and inhibition of Hedgehog
signaling.35
VE-cadherin thus seems to play a central role in the
regulation of endoneurial endothelial vascular perme-
ability, similarly to that of N-cadherin in neural progeni-
tor cells, which is at the center of the Wnt/Hedgehog
crosstalk observed in these cells.36
In the CCI model, alterations in the epineural blood
ﬂow resulting from the loose ligatures around the
nerve induce focal nerve ischemia, an important initial
Figure 5. In vivo, at 3 h post-injury, CCI of the infraorbital
nerve elicited a significant increase in hypoxia marker
HIF-1a mRNA expression levels as compared to sham-injured
animals. Changes in HIF-1a mRNA levels were assessed in the
IoN of CCI-injured animals compared to sham-injured controls,
using semi-quantitative RT-PCR analyses. Data are presented as
relative quantification (R.Q.) in arbitrary units (A.U.)
corresponding to the ratio of specific mRNA over
RPS18 mRNA. Each bar corresponds to the mean SEM of
n¼ 5–6 animals for each condition; *p< 0.05; Mann–Whitney
test was used.
CCI: chronic constriction injury; HIF-1a: hypoxia-inducible
factor-1a; IoN: infraorbital nerve; RT-PCR: reverse transcription
polymerase chain reaction; SEM: standard error of the mean.
Figure 6. In vivo, at 3 h post-injury, CCI of the infraorbital
nerve elicited a significant increase in chemokine marker CCL2
mRNA expression levels as compared to sham-injured animals.
Changes in CCL2 mRNA levels were assessed in the IoN of
CCI-injured animals compared to sham-injured controls, using
semi-quantitative RT-PCR analyses. Data are presented as
relative quantification (R.Q.) in arbitrary units (A.U.)
corresponding to the ratio of specific mRNA over
RPS18 mRNA. Each bar corresponds to the mean SEM of
n¼ 5–6 animals for each condition; *p< 0.05; Mann–Whitney
test was used.
CCI: chronic constriction injury; CCL2: chemokine (CC motif)
ligand 2; IoN: infraorbital nerve; RT-PCR: reverse transcription
polymerase chain reaction; SEM: standard error of the mean.
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pathogenic mechanism in the development of the painful
phenotype.37 The resulting hypoxia, as conﬁrmed in the
present study using the HIF-1a marker (Figure 5), could
trigger the release of VEGF by resident macrophages2
leading to the phosphorylation and subsequent internal-
ization of VE-cadherin.27,38 Furthermore, the shear stress
generated by the altered blood ﬂow could also induce the
phosphorylation of VE-cadherin39 also leading to its sub-
sequent internalization (via the mechanosensor complex
VE-Cadherin/VEGFR240). Apart from the vascular alter-
ations, the CCI model is also associated with signiﬁcant
hypoxic nerve damage, translating as signiﬁcant increases
in the HIF-1amarker and in the chemokine CCL2 marker
(Figure 6), released in peripheral nerve injuries to attract
macrophages to the site of injury, as part of the physio-
logical Wallerian degeneration.3,41
The hypothesized molecular alterations underlying
CCI-induced BNB disruption are summarized in
Figure 7.
Conclusion
A crosstalk between Wnt/b-catenin- and SHH-mediated
signaling pathways within EECs could mediate the
Figure 7. Simplified modelization of the neuro-immuno-vascular interactions within endoneurial endothelial cells of nerves subjected to
chronic constriction injury (CCI). In this model, Claudin-5 was chosen to illustrate the key role of TJ proteins in the disruption of the
blood–nerve barrier following CCI, as it has been previously described as the main endoneurial endothelial TJ protein within peripheral
nerves.42,43 Other TJ proteins (such as Claudin-1 or Occludin) although not described in this model are of critical importance in the
regulation of BNB permeability. Justifications of the proposed model based on past and current results (in italic) and available (nonex-
haustive) scientific literature are described hereafter: a, b: Vos et al.,25 Myers et al.,37 Bennett and Xie.44 c: Myers et al.,37 Bennett and Xie,44
Walsh et al.45 d: Myers et al.,37 Nukada et al.,46 Lim et al.33 e: Figure 5; Lim et al.2,33 f: Figure 5; Van Steenwinckel et al.,3 Moreau et al.,4
Sapienza et al.41 g: Figure 3(b) and (c). h: Figure 5; Coon et al.,40 Walsh et al.45 i: Lim et al.2 j: Van Steenwinckel et al.,3 Sapienza et al.41 k: Van
Steenwinckel et al.,3 Sapienza et al.41 l: Lim et al.2 m: Figure 1(d) and data not shown (see Results section for details); Gavard,27 Gavard and
Gutkind.38 n: Disorganization of AJ/TJ proteins24 induces loss of cell polarity34 resulting in loss of primary cilium35 and subsequent
inhibition of Hedgehog pathway.35 o: Gavard and Gutkind,24 Taddei et al.26 p: Figures 3(a) and 4(c). q: Moreau et al.4,5 r: Figures 3(c) and 4(a);
Taddei et al.26 s: Figure 4(a) and (e); Moreau et al.4,5, Gavard and Gutkind.24 t: Lim et al.,2 Moreau et al.4,5 u: Figure 4(b); Lim et al.,2 Moreau
et al.4,5 v: Moreau et al.,4,5 Myers and Shubayev.47 w: Kiguchi et al.,30 Xie et al.,48 Basbaum et al.49.
BNB: blood–nerve barrier; TJ: tight junction.
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chronic disruption of the BNB following peripheral
nerve injury (CCI). Internalization of AJ protein VE-
cadherin and concurrent downregulation of the key TJ
proteins Claudin-1, Claudin-5, and Occludin could drive
such BNB disruption, responsible for subsequent blood-
borne immunocytes/toxic molecules inﬁltration resulting
in local neuroinﬂammation, peripheral sensitization, and
neuropathic pain development.
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